Genetic Testing in Endometrial Cancer

• Alkushi A, Köbel M, Kalloger SE, Gilks CB (2010) High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes. Int J Gynecol Pathol 29(4):343–350

  Article  PubMed  Google Scholar 

• Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I (2005) Endometrial cancer. Lancet 366(9484):491–505

  Article  PubMed  Google Scholar 

• Ambros RA, Sheehan CE, Kallakury BV, Ross JS, Malfetano J, Paunovich E, Figge J (1996) MDM2 and p53 protein expression in the histologic subtypes of endometrial carcinoma. Mod Pathol 9(12):1165–1169

  CAS  PubMed  Google Scholar 

• Arora N (2020) Hereditary endometrial cancers. In: Mehta S, Gupta B (eds) Recent advances in endometrial cancer. Springer, Singapore, pp 77–95

  Chapter  Google Scholar 

• Banno K, Yanokura M, Susumu N, Kawaguchi M, Hirao N, Hirasawa A, Tsukazaki K, Aoki D (2006) Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer. Oncol Rep 16(6):1189–1196

  CAS  PubMed  Google Scholar 

• Bell DW, Ellenson LH (2019) Molecular genetics of endometrial carcinoma. Annu Rev Pathol 14:339–367

  Article  CAS  PubMed  Google Scholar 

• Bianco B, Barbosa CP, Trevisan CM, Laganà AS, Montagna E (2020) Endometrial cancer: a genetic point of view. Transl Cancer Res 9(12):7706

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Blakely T, Barendregt JJ, Foster RH, Hill S, Atkinson J, Sarfati D, Edwards R (2013) The association of active smoking with multiple cancers: national census-cancer registry cohorts with quantitative bias analysis. Cancer Causes Control 24(6):1243–1255

  Article  PubMed  Google Scholar 

• Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15(1):10–17

  Article  CAS  PubMed  Google Scholar 

• Bonadona V, Bonaïti B, Olschwang S, Grandjouan S, Huiart L, Longy M, Guimbaud R, Buecher B, Bignon Y-J, Caron O, Colas C, Noguès C, Lejeune-Dumoulin S, Olivier-Faivre L, Polycarpe-Osaer F, Nguyen TD, Desseigne F, Saurin J-C, Berthet P, French Cancer Genetics Network (2011) Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in lynch syndrome. JAMA 305(22):2304–2310

  Article  CAS  PubMed  Google Scholar 

• Byron SA, Gartside M, Powell MA, Wellens CL, Gao F, Mutch DG, Goodfellow PJ, Pollock PM (2012) FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features. PLoS One 7(2):e30801

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Castellano E, Downward J (2011) RAS interaction with PI3K: more than just another effector pathway. Genes Cancer 2(3):261–274

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Chan QKY, Khoo U-S, Chan KYK, Ngan HYS, Li S-S, Chiu P-M, Man L-S, Ip PPC, Xue W-C, Cheung ANY (2005) Promoter methylation and differential expression of π-class glutathione S-transferase in endometrial carcinoma. J Mol Diagn 7(1):8–16

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Chandler RL et al. (2015) Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through protumorigenic inflammatory cytokine signalling. Nat Commun 6:6118. http://doi.org/10.1038/ncomms7118

  Google Scholar 

• Cherniack AD, Shen H, Walter V, Stewart C, Murray BA, Bowlby R, Hu X, Ling S, Soslow RA, Broaddus RR, Zuna RE, Robertson G, Laird PW, Kucherlapati R, Mills GB, Weinstein JN, Zhang J, Akbani R, Levine DA, Cancer Genome Atlas Research Network (2017) Integrated molecular characterization of uterine carcinosarcoma. Cancer Cell 31(3):411–423

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Cheung LWT, Hennessy BT, Li J, Yu S, Myers AP, Djordjevic B, Lu Y, Stemke-Hale K, Dyer MD, Zhang F (2011) High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability. Cancer Discov 1(2):170–185

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Coll-de la Rubia E, Martinez-Garcia E, Dittmar G, Gil-Moreno A, Cabrera S, Colas E (2020) Prognostic biomarkers in endometrial cancer: a systematic review and meta-analysis. J Clin Med 9(6):E1900

  Article  Google Scholar 

• Cuevas IC, Sahoo SS, Kumar A, Zhang H, Westcott J, Aguilar M, Cortez JD, Sullivan SA, Xing C, Hayes DN, Brekken RA, Bae-Jump VL, Castrillon DH (2019) Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition. Proc Natl Acad Sci 116(51):25880–25890

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• D’Alessandris N, Travaglino A, Santoro A, Arciuolo D, Scaglione G, Raffone A, Inzani F, Zannoni GF (2021) TCGA molecular subgroups of endometrial carcinoma in ovarian endometrioid carcinoma: a quantitative systematic review. Gynecol Oncol 163(2):427–432

  Article  PubMed  Google Scholar 

• Depreeuw J, Stelloo E, Osse EM, Creutzberg CL, Nout RA, Moisse M, Garcia-Dios DA, Dewaele M, Willekens K, Marine J-C, Matias-Guiu X, Amant F, Lambrechts D, Bosse T (2017) Amplification of 1q32.1 refines the molecular classification of endometrial carcinoma. Clin Cancer Res 23(23):7232–7241

  Article  CAS  PubMed  Google Scholar 

• Dowdy SC, Gostout BS, Shridhar V, Wu X, Smith DI, Podratz KC, Jiang S-W (2005) Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines. Gynecol Oncol 99(1):126–134

  Article  CAS  PubMed  Google Scholar 

• Eichhorn PJA, Creyghton MP, Bernards R (2009) Protein phosphatase 2A regulatory subunits and cancer. Biochim Biophys Acta 1795(1):1–15

  CAS  PubMed  Google Scholar 

• Engelman JA (2009) Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 9(8):550–562

  Article  CAS  PubMed  Google Scholar 

• Fiolka R, Zubor P, Janusicova V, Visnovsky J, Mendelova A, Kajo K, Lasabova Z, Plank L, Danko J (2013) Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer. Oncol Rep 30(6):2878–2886

  Article  CAS  PubMed  Google Scholar 

• Guan B, Mao T-L, Panuganti PK, Kuhn E, Kurman RJ, Maeda D, Chen E, Jeng Y-M, Wang T-L, Shih I-M (2011) Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma. Am J Surg Pathol 35(5):625

  Article  PubMed  PubMed Central  Google Scholar 

• Hu R, Hilakivi-Clarke L, Clarke R (2015) Molecular mechanisms of tamoxifen-associated endometrial cancer. Oncol Lett 9(4):1495–1501

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Inoue F, Sone K, Toyohara Y, Takahashi Y, Kukita A, Hara A, Taguchi A, Tanikawa M, Tsuruga T, Osuga Y (2021) Targeting epigenetic regulators for endometrial cancer therapy: its molecular biology and potential clinical applications. Int J Mol Sci 22(5):2305

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Jia S, Yang Y, Lang J, Sun P, Leng J (2013) Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis. Hum Reprod 28(2):322–330

  Article  CAS  PubMed  Google Scholar 

• Karageorgi S, Hankinson SE, Kraft P, De Vivo I (2010) Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the nurses’ health study cohort 1976–2004. Int J Cancer 126(1):208–216

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Kinde I, Bettegowda C, Wang Y, Wu J, Agrawal N, Shih I-M, Kurman R, Dao F, Levine DA, Giuntoli R, Roden R, Eshleman JR, Carvalho JP, Marie SKN, Papadopoulos N, Kinzler KW, Vogelstein B, Diaz LA (2013) Evaluation of DNA from the papanicolaou test to detect ovarian and endometrial cancers. Sci Transl Med 5(167):167ra4

  Article  PubMed  PubMed Central  Google Scholar 

• Konopka B, Janiec Jankowska A, Kwiatkowska E, Najmoła U, Bidziński M, Olszewski W, Goluda C (2011) PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors. Hum Pathol 42(11):1710–1719

  Article  CAS  PubMed  Google Scholar 

• Lax SF, Kendall B, Tashiro H, Slebos RJC, Ellenson LH (2000) The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways. Cancer 88(4):814–824

  Article  CAS  PubMed  Google Scholar 

• Lee J-W, Park Y-A, Choi J-J, Lee YY, Kim C-J, Choi C, Kim T-J, Lee NW, Kim B-G, Bae D-S (2011) The expression of the miRNA-200 family in endometrial endometrioid carcinoma. Gynecol Oncol 120(1):56–62

  Article  CAS  PubMed  Google Scholar 

• León-Castillo A, Britton H, McConechy MK, McAlpine JN, Nout R, Kommoss S, Brucker SY, Carlson JW, Epstein E, Rau TT (2020) Interpretation of somatic POLE mutations in endometrial carcinoma. J Pathol 250(3):323–335

  Article  PubMed  PubMed Central  Google Scholar 

• Levine DA, Network CGAR (2013) Integrated genomic characterization of endometrial carcinoma. Nature 497(7447):67–73

  Article  PubMed  PubMed Central  Google Scholar 

• Liu Y, Patel L, Mills GB, Lu KH, Sood AK, Ding L, Kucherlapati R, Mardis ER, Levine DA, Shmulevich I, Broaddus RR, Zhang W (2014) Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma. J Natl Cancer Inst 106(9):dju245

  Article  PubMed  PubMed Central  Google Scholar 

• López-Reig R, Fernández-Serra A, Romero I, Zorrero C, Illueca C, García-Casado Z, Poveda A, López-Guerrero JA (2019) Prognostic classification of endometrial cancer using a molecular approach based on a twelve-gene NGS panel. Sci Rep 9(1):1

  Article  Google Scholar 

• Low YL, Li Y, Humphreys K, Thalamuthu A, Li Y, Darabi H, Wedrén S, Bonnard C, Czene K, Iles MM, Heikkinen T, Aittomäki K, Blomqvist C, Nevanlinna H, Hall P, Liu ET, Liu J (2010) Multi-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility. PLoS Genet 6(7):e1001012

  Article  PubMed  PubMed Central  Google Scholar 

• Lucenteforte E, Talamini R, Montella M, Maso LD, Pelucchi C, Franceschi S, La Vecchia C, Negri E (2009) Family history of cancer and the risk of endometrial cancer. Eur J Cancer Prev 18(2):95–99

  Article  PubMed  Google Scholar 

• Lv S, Xu X, Wu Z (2019) Identification of key candidate genes and pathways in endometrial cancer: evidence from bioinformatics analysis. Oncol Lett 18(6):6679–6689

  CAS  PubMed  PubMed Central  Google Scholar 

• McMeekin DS, Tritchler DL, Cohn DE, Mutch DG, Lankes HA, Geller MA, Powell MA, Backes FJ, Landrum LM, Zaino R (2016) Clinicopathologic significance of mismatch repair defects in endometrial cancer: an NRG oncology/gynecologic oncology group study. J Clin Oncol 34(25):3062

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Miller EM, Patterson NE, Zechmeister JM, Bejerano-Sagie M, Delio M, Patel K, Ravi N, Quispe-Tintaya W, Maslov A, Simmons N, Castaldi M, Vijg J, Karabakhtsian RG, Greally JM, Kuo DYS, Montagna C (2017) Development and validation of a targeted next generation DNA sequencing panel outperforming whole exome sequencing for the identification of clinically relevant genetic variants. Oncotarget 8(60):102033–102045. https://doi.org/10.18632/oncotarget.22116

  Article  PubMed  PubMed Central  Google Scholar 

• Moreno-Bueno G, Hardisson D, Sanchez C, Sarrio D, Cassia R, García-Rostán G, Prat J, Guo M, Herman JG, Matías-Guiu X (2002) Abnormalities of the APC/β-catenin pathway in endometrial cancer. Oncogene 21(52):7981–7990

  Article  CAS  PubMed  Google Scholar 

• Nakashima R, Fujita M, Enomoto T, Haba T, Yoshino K, Wada H, Kurachi H, Sasaki M, Wakasa K, Inoue M (1999) Alteration of p16 and p15 genes in human uterine tumours. Br J Cancer 80(3):458–467

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Netzer IM, Kerner H, Litwin L, Lowenstein L, Amit A (2011) Diagnostic implications of p16 expression in serous papillary endometrial cancer. Int J Gynecol Cancer 21(8):1441

  Article  PubMed  Google Scholar 

• O’Hara AJ, Bell DW (2012) The genomics and genetics of endometrial cancer. Adv Genomics Genet 2012(2):33

  PubMed  PubMed Central  Google Scholar 

• Okuda T, Sekizawa A, Purwosunu Y, Nagatsuka M, Morioka M, Hayashi M, Okai T (2010) Genetics of endometrial cancers. Obstet Gynecol Int 2010:984013

  Article  PubMed  PubMed Central  Google Scholar 

• Reid-Nicholson M, Iyengar P, Hummer AJ, Linkov I, Asher M, Soslow RA (2006) Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis. Mod Pathol 19(8):1091–1100

  Article  CAS  PubMed  Google Scholar 

• Rudd ML, Price JC, Fogoros S, Godwin AK, Sgroi DC, Merino MJ, Bell DW (2011) A unique spectrum of somatic PIK3CA (p110α) mutations within primary endometrial carcinomas. Clin Cancer Res 17(6):1331–1340

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Salvesen HB, Kumar R, Stefansson I, Angelini S, MacDonald N, Smeds J, Jacobs IJ, Hemminki K, Das S, Akslen LA (2005) Low frequency of BRAF and CDKN2A mutations in endometrial cancer. Int J Cancer 115(6):930–934

  Article  CAS  PubMed  Google Scholar 

• Semczuk A, Boltze C, Marzec B, Szczygielska A, Roessner A, Schneider-Stock R (2003) P16 INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas. J Cancer Res Clin Oncol 129(10):589–596

  Article  CAS  PubMed  Google Scholar 

• Serra S, Chetty R (2018) Rnf43. J Clin Pathol 71(1):1–6

  Article  PubMed  Google Scholar 

• Singh N, Piskorz AM, Bosse T, Jimenez-Linan M, Rous B, Brenton JD, Gilks CB, Köbel M (2020) P53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies. J Pathol 250(3):336–345

  Article  CAS  PubMed  Google Scholar 

• Travaglino A, Raffone A, Raimondo D, Reppuccia S, Ruggiero A, Arena A, Casadio P, Zullo F, Insabato L, Seracchioli R, Mollo A (2022) Prognostic significance of CTNNB1 mutation in early stage endometrial carcinoma: a systematic review and meta-analysis. Arch Gynecol Obstet 306(2):423–431

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Urick ME, Rudd ML, Godwin AK, Sgroi D, Merino M, Bell DW (2011) PIK3R1 (p85α) is somatically mutated at high frequency in primary endometrial cancer. Cancer Res 71(12):4061–4067

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Walker CJ, O’Hern MJ, Serna VA, Kurita T, Miranda MA, Sapp CE, Mutch DG, Cohn DE, Goodfellow PJ (2017) Novel SOX17 frameshift mutations in endometrial cancer are functionally distinct from recurrent missense mutations. Oncotarget 8(40):68758

  Article  PubMed  PubMed Central  Google Scholar 

• Webb PM (2015) Environmental (nongenetic) factors in gynecological cancers: update and future perspectives. Future Oncol 11(2):295–307

  Article  CAS  PubMed  Google Scholar 

• Whitcomb BP, Mutch DG, Herzog TJ, Rader JS, Gibb RK, Goodfellow PJ (2003) Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma. Clin Cancer Res 9(6):2277–2287

  CAS  PubMed  Google Scholar 

• Wiegand KC, Lee AF, Al-Agha OM, Chow C, Kalloger SE, Scott DW, Steidl C, Wiseman SM, Gascoyne RD, Gilks B (2011) Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas. J Pathol 224(3):328–333

  Article  CAS  PubMed  Google Scholar 

• Wiegand KC, Hennessy BT, Leung S, Wang Y, Ju Z, McGahren M, Kalloger SE, Finlayson S, Stemke-Hale K, Lu Y, Zhang F, Anglesio MS, Gilks B, Mills GB, Huntsman DG, Chandler RL, Damrauer JS, Raab JR, Schisler JC, Wilkerson MD, Didion JP, Starmer J, Serber D, Yee D, Xiong J, Darr DB, Pardo-Manuel de Villena F, Kim WY, Magnuson T (2015) Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling. Nat Commun 6:6118

  Article  Google Scholar 

• Wright K, Wilson P, Morland S, Campbell I, Walsh M, Hurst T, Ward B, Cummings M, Chenevix-Trench G (1999) β-Catenin mutation and expression analysis in ovarian cancer: exon 3 mutations and nuclear translocation in 16% of endometrioid tumours. Int J Cancer 82(5):625–629

  Article  CAS  PubMed  Google Scholar 

• Xu W, Xiang Y, Ruan Z, Zheng W, Cheng J, Dai Q, Gao Y, Shu X (2004) Menstrual and reproductive factors and endometrial cancer risk: results from a population-based case-control study in urban Shanghai. Int J Cancer 108(4):613–619

  Article  CAS  PubMed  Google Scholar 

• Yang HP, Wentzensen N, Trabert B, Gierach GL, Felix AS, Gunter MJ, Hollenbeck A, Park Y, Sherman ME, Brinton LA (2013) Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP diet and health study. Am J Epidemiol 177(2):142–151

  Article  PubMed  Google Scholar 

• Yanokura M, Banno K, Iida M, Irie H, Umene K, Masuda K, Kobayashi Y, Tominaga E, Aoki D (2015) MicroRNAS in endometrial cancer: recent advances and potential clinical applications. EXCLI J 14:190–198

  PubMed  PubMed Central  Google Scholar 

• Yemelyanova A, Ji H, Shih I-M, Wang T-L, Ronnett BM (2009) Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases. Am J Surg Pathol 33(10):1504–1514

  Article  PubMed  Google Scholar 

Download references